Skip to main content

Migraine Prophylaxis News

Oral Health Linked To Migraines, Fibromyalgia

TUESDAY, May 20, 2025 — Women who don’t brush and floss frequently are more likely to suffer from migraines and fibromyalgia, a new study says. Women with the worst oral health have a 60% higher risk ...

Ubrogepant (Ubrelvy) Effective Against Early Migraine Symptoms

WEDNESDAY, May 14, 2025 – Migraines don’t just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What’s more, those n...

Ubrogepant During Prodromal Phase of Migraine Eases Symptoms

TUESDAY, May 13, 2025 – Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published online May 12 in Nature Medicine. Peter J. Goadsby,...

Stroke Among Younger Adults Linked To Non-Traditional Risks

FRIDAY, April 18, 2025 – Migraines, blood clots in veins, kidney or liver disease, and cancer aren’t typically considered conditions that put a person at increased danger for stroke. But these l...

Lower Oral Health Scores Linked to Higher Pain Scores in Women

MONDAY, April 14, 2025 – Low oral health scores are associated with higher pain scores, including migraine headache, among women, according to a study published online April 9 in Frontiers in Pain...

ACP Issues Clinical Guideline for Pharmacologic Treatment of Acute Episodic Migraine

FRIDAY, March 21, 2025 – In a clinical guideline issued by the American College of Physicians (ACP) and published online March 18 in the Annals of Internal Medicine, recommendations are presented ...

Combination Therapy Recommended For Migraines

THURSDAY, March 20, 2025 – Doctors should prescribe triptans for migraine patients who aren’t receiving relief from over-the-counter (OTC) pain relievers, according to a new clinical guideline from t...

AAN: Prophylactic Zonisamide Effective in Pediatric Migraine

MONDAY, March 3, 2025 – For pediatric patients with migraine, prophylactic zonisamide use can significantly reduce the median number of headache days per month (HDPM), according to a study scheduled...

ACP Issues Clinical Guideline for Pharmacologic Prevention of Episodic Migraine

MONDAY, Feb. 10, 2025 – In a clinical guideline issued by the American College of Physicians and published online Feb. 4 in the Annals of Internal Medicine, recommendations are presented regarding...

Minority Children Less Likely to Be Diagnosed With Migraine in Emergency Department

WEDNESDAY, Feb. 5, 2025 – Compared with non-Hispanic White (NHW) children, non-Hispanic Black (NHB) and Hispanic/Latino (HL) children with a headache diagnosis in the emergency department have lower...

Too Often, ER Docs Don't Spot Migraines in Minority Kids

THURSDAY, Feb. 6, 2025 – Kids and teens can also get migraines, but Black and Hispanic children seen in ERs are more likely to have their condition go undiagnosed, new research shows. That's...

FDA Approves Symbravo for Acute Treatment of Migraine in Adults

WEDNESDAY, Feb. 5, 2025 – The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults. The approval was ...

Beta Blocker Propranolol Might Reduce Migraine Stroke Risk

MONDAY, Feb. 3, 2025 – A common drug used to prevent migraines might have an additional benefit – protecting women against stroke. Women taking the beta blocker propranolol to ward off migraines...

Propranolol May Reduce Overall Stroke Risk in Women With Migraine

FRIDAY, Jan. 31, 2025 – Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke, according to a study...

Quick Fix? New Migraine Medicine, Qulipta, May Start Working Right Away

THURSDAY, Dec. 26, 2024 – Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent their terrible symptoms. But a recently approved daily...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Migraine

Related drug support groups

clonazepam, lisinopril, metoprolol, bupropion, amlodipine, amitriptyline, propranolol, Topamax, pregabalin, view more... lamotrigine, Depakote, atenolol, baclofen, topiramate, clonidine, nortriptyline, Botox, Emgality, Aimovig, erenumab, Ajovy, verapamil, Qulipta, nifedipine, Nurtec ODT